Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Other Non-Current Liabilities (2016 - 2025)

Historic Other Non-Current Liabilities for Integra Lifesciences Holdings (IART) over the last 17 years, with Q3 2025 value amounting to $233.3 million.

  • Integra Lifesciences Holdings' Other Non-Current Liabilities rose 2289.0% to $233.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $233.3 million, marking a year-over-year increase of 2289.0%. This contributed to the annual value of $146.2 million for FY2024, which is 2685.91% down from last year.
  • Latest data reveals that Integra Lifesciences Holdings reported Other Non-Current Liabilities of $233.3 million as of Q3 2025, which was up 2289.0% from $253.2 million recorded in Q2 2025.
  • Integra Lifesciences Holdings' 5-year Other Non-Current Liabilities high stood at $253.2 million for Q2 2025, and its period low was $63.7 million during Q3 2022.
  • Its 5-year average for Other Non-Current Liabilities is $150.6 million, with a median of $146.2 million in 2024.
  • Per our database at Business Quant, Integra Lifesciences Holdings' Other Non-Current Liabilities plummeted by 5623.67% in 2022 and then surged by 12337.08% in 2023.
  • Quarter analysis of 5 years shows Integra Lifesciences Holdings' Other Non-Current Liabilities stood at $120.3 million in 2021, then grew by 15.17% to $138.5 million in 2022, then surged by 44.36% to $199.9 million in 2023, then fell by 26.86% to $146.2 million in 2024, then soared by 59.5% to $233.3 million in 2025.
  • Its Other Non-Current Liabilities stands at $233.3 million for Q3 2025, versus $253.2 million for Q2 2025 and $160.5 million for Q1 2025.